These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 30553134)
21. MicroRNA-506 is up-regulated in the development of pancreatic ductal adenocarcinoma and is associated with attenuated disease progression. Cheng RF; Wang J; Zhang JY; Sun L; Zhao YR; Qiu ZQ; Sun BC; Sun Y Chin J Cancer; 2016 Jul; 35(1):64. PubMed ID: 27371108 [TBL] [Abstract][Full Text] [Related]
22. miR-26b enhances the sensitivity of hepatocellular carcinoma to Doxorubicin via USP9X-dependent degradation of p53 and regulation of autophagy. Chen E; Li E; Liu H; Zhou Y; Wen L; Wang J; Wang Y; Ye L; Liang T Int J Biol Sci; 2021; 17(3):781-795. PubMed ID: 33767588 [TBL] [Abstract][Full Text] [Related]
23. Circulating microRNAs as Potential Diagnostic, Prognostic and Therapeutic Targets in Pancreatic Cancer. Ebrahimi S; Hosseini M; Ghasemi F; Shahidsales S; Maftouh M; Akbarzade H; Parizadeh SA; Hassanian SM; Avan A Curr Pharm Des; 2016; 22(42):6444-6450. PubMed ID: 27539232 [TBL] [Abstract][Full Text] [Related]
24. WIPF1 antagonizes the tumor suppressive effect of miR-141/200c and is associated with poor survival in patients with PDAC. Pan Y; Lu F; Xiong P; Pan M; Zhang Z; Lin X; Pan M; Huang H J Exp Clin Cancer Res; 2018 Jul; 37(1):167. PubMed ID: 30041660 [TBL] [Abstract][Full Text] [Related]
25. MicroRNA-891b is an independent prognostic factor of pancreatic cancer by targeting Cbl-b to suppress the growth of pancreatic cancer cells. Dong Q; Li C; Che X; Qu J; Fan Y; Li X; Li Y; Wang Q; Liu Y; Yang X; Qu X Oncotarget; 2016 Dec; 7(50):82338-82353. PubMed ID: 27494897 [TBL] [Abstract][Full Text] [Related]
26. Clinical potential of microRNAs in pancreatic ductal adenocarcinoma. Steele CW; Oien KA; McKay CJ; Jamieson NB Pancreas; 2011 Nov; 40(8):1165-71. PubMed ID: 22001830 [TBL] [Abstract][Full Text] [Related]
27. MicroRNA-183 is involved in cell proliferation, survival and poor prognosis in pancreatic ductal adenocarcinoma by regulating Bmi-1. Zhou L; Zhang WG; Wang DS; Tao KS; Song WJ; Dou KF Oncol Rep; 2014 Oct; 32(4):1734-40. PubMed ID: 25109303 [TBL] [Abstract][Full Text] [Related]
28. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4. Fu Y; Liu X; Chen Q; Liu T; Lu C; Yu J; Miao Y; Wei J J Exp Clin Cancer Res; 2018 Jul; 37(1):130. PubMed ID: 29970191 [TBL] [Abstract][Full Text] [Related]
29. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer. Deng X; Cao M; Zhang J; Hu K; Yin Z; Zhou Z; Xiao X; Yang Y; Sheng W; Wu Y; Zeng Y Biomaterials; 2014 May; 35(14):4333-44. PubMed ID: 24565525 [TBL] [Abstract][Full Text] [Related]
30. miR-186 and 326 predict the prognosis of pancreatic ductal adenocarcinoma and affect the proliferation and migration of cancer cells. Zhang ZL; Bai ZH; Wang XB; Bai L; Miao F; Pei HH PLoS One; 2015; 10(3):e0118814. PubMed ID: 25742499 [TBL] [Abstract][Full Text] [Related]
31. HnRNPK/miR-223/FBXW7 feedback cascade promotes pancreatic cancer cell growth and invasion. He D; Huang C; Zhou Q; Liu D; Xiong L; Xiang H; Ma G; Zhang Z Oncotarget; 2017 Mar; 8(12):20165-20178. PubMed ID: 28423622 [TBL] [Abstract][Full Text] [Related]
32. A novel feedback loop between high MALAT-1 and low miR-200c-3p promotes cell migration and invasion in pancreatic ductal adenocarcinoma and is predictive of poor prognosis. Zhuo M; Yuan C; Han T; Cui J; Jiao F; Wang L BMC Cancer; 2018 Oct; 18(1):1032. PubMed ID: 30352575 [TBL] [Abstract][Full Text] [Related]
33. Deubiquitinase USP9X promotes cell migration, invasion and inhibits apoptosis of human pancreatic cancer. Liu L; Yao D; Zhang P; Ding W; Zhang X; Zhang C; Gong S; Zhang Y; Wang J; Sun T; Ren Z Oncol Rep; 2017 Dec; 38(6):3531-3537. PubMed ID: 29130109 [TBL] [Abstract][Full Text] [Related]
34. MiRNA-615-5p functions as a tumor suppressor in pancreatic ductal adenocarcinoma by targeting AKT2. Sun Y; Zhang T; Wang C; Jin X; Jia C; Yu S; Chen J PLoS One; 2015; 10(4):e0119783. PubMed ID: 25856297 [TBL] [Abstract][Full Text] [Related]
35. A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma. Indolfi L; Ligorio M; Ting DT; Xega K; Tzafriri AR; Bersani F; Aceto N; Thapar V; Fuchs BC; Deshpande V; Baker AB; Ferrone CR; Haber DA; Langer R; Clark JW; Edelman ER Biomaterials; 2016 Jul; 93():71-82. PubMed ID: 27082874 [TBL] [Abstract][Full Text] [Related]
36. Manganese superoxide dismutase expression is negatively associated with microRNA-301a in human pancreatic ductal adenocarcinoma. Pandit H; Zhang W; Li Y; Agle S; Li X; Li SP; Cui G; Li Y; Martin RC Cancer Gene Ther; 2015 Oct; 22(10):481-6. PubMed ID: 26384137 [TBL] [Abstract][Full Text] [Related]
37. Long noncoding RNA MIR31HG exhibits oncogenic property in pancreatic ductal adenocarcinoma and is negatively regulated by miR-193b. Yang H; Liu P; Zhang J; Peng X; Lu Z; Yu S; Meng Y; Tong WM; Chen J Oncogene; 2016 Jul; 35(28):3647-57. PubMed ID: 26549028 [TBL] [Abstract][Full Text] [Related]
38. Expression and functional perspectives of miR-184 in pancreatic ductal adenocarcinoma. Li H; Xiang H; Ge W; Wang H; Wang T; Xiong M Int J Clin Exp Pathol; 2015; 8(10):12313-8. PubMed ID: 26722418 [TBL] [Abstract][Full Text] [Related]
39. Diagnostic and biological significance of microRNA-192 in pancreatic ductal adenocarcinoma. Zhao C; Zhang J; Zhang S; Yu D; Chen Y; Liu Q; Shi M; Ni C; Zhu M Oncol Rep; 2013 Jul; 30(1):276-84. PubMed ID: 23612862 [TBL] [Abstract][Full Text] [Related]
40. Overexpressions of miR-212 are associated with poor prognosis of patients with pancreatic ductal adenocarcinoma. Wu Z; Zhou L; Ding G; Cao L Cancer Biomark; 2017; 18(1):35-39. PubMed ID: 27814273 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]